In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

Neumora Therapeutics said on Thursday its experimental drug to treat depression failed to meet the main goal of a late-stage study. The study, first of the three late-stage trials, was testing the ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

The technology is not new. It’s been around since ... For many patients, after six weeks their depression resolves. For others, they may need more treatment. Overall, the program has had high ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Iregui said taking the drug allowed him to discover new perspectives about his emotions ... resulted in significant reductions in depression among subjects, “measurably greater” than ...

The technology is not new. It's been around since ... For many patients, after six weeks their depression resolves. For others, they may need more treatment. Overall, the program has had high ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...

Millions of Brits could be at risk of medication-induced depression from taking heartburn pills and range of other common routine medications. Proton pump inhibitors (PPIs), a type of medication ...

Assoc Prof Cocchi said the new treatment was the result of decades ... brain networks that link to the severity of symptoms of depression, and help us to develop a personalised approach so we ...